Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy

NCT06437431 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

304

Enrollment

NETWORK

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: glenzocimab
DRUG: placebo

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild